IRIS Accounts Production v24.3.0.553 07837258 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078372582022-11-30078372582023-11-30078372582022-12-012023-11-30078372582021-11-30078372582021-12-012022-11-30078372582022-11-3007837258ns15:EnglandWales2022-12-012023-11-3007837258ns14:PoundSterling2022-12-012023-11-3007837258ns10:Director12022-12-012023-11-3007837258ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007837258ns10:SmallEntities2022-12-012023-11-3007837258ns10:AuditExemptWithAccountantsReport2022-12-012023-11-3007837258ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007837258ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3007837258ns10:FullAccounts2022-12-012023-11-3007837258ns10:RegisteredOffice2022-12-012023-11-3007837258ns5:CurrentFinancialInstruments2023-11-3007837258ns5:CurrentFinancialInstruments2022-11-3007837258ns5:Non-currentFinancialInstruments2023-11-3007837258ns5:Non-currentFinancialInstruments2022-11-3007837258ns5:ShareCapital2023-11-3007837258ns5:ShareCapital2022-11-3007837258ns5:RetainedEarningsAccumulatedLosses2023-11-3007837258ns5:RetainedEarningsAccumulatedLosses2022-11-3007837258ns5:ComputerEquipment2022-12-012023-11-3007837258ns5:PlantMachinery2022-11-3007837258ns5:PlantMachinery2022-12-012023-11-3007837258ns5:PlantMachinery2023-11-3007837258ns5:PlantMachinery2022-11-3007837258ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3007837258ns5:WithinOneYearns5:CurrentFinancialInstruments2022-11-3007837258ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-11-3007837258ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2022-11-3007837258ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-11-3007837258ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-11-30
REGISTERED NUMBER: 07837258 (England and Wales)




















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2023

FOR

VASCULAR SONOGRAPHIC DS LIMITED

VASCULAR SONOGRAPHIC DS LIMITED (REGISTERED NUMBER: 07837258)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 6

VASCULAR SONOGRAPHIC DS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: Mrs S Chowdhury





REGISTERED OFFICE: 7 Highfields
Cuffley
Potters Bar
Hertfordshire
EN6 4EL





REGISTERED NUMBER: 07837258 (England and Wales)





ACCOUNTANTS: KBSP Partners LLP
Chartered Accountants
Harben House
Harben Parade
Finchley Road
LONDON
NW3 6LH

VASCULAR SONOGRAPHIC DS LIMITED (REGISTERED NUMBER: 07837258)

BALANCE SHEET
30 NOVEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 175 219

CURRENT ASSETS
Debtors 5 59,705 43,309
Cash at bank 17,081 8,528
76,786 51,837
CREDITORS
Amounts falling due within one year 6 64,889 33,300
NET CURRENT ASSETS 11,897 18,537
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,072

18,756

CREDITORS
Amounts falling due after more than one
year

7

(10,734

)

(17,298

)

PROVISIONS FOR LIABILITIES (44 ) (54 )
NET ASSETS 1,294 1,404

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 294 404
SHAREHOLDERS' FUNDS 1,294 1,404

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 November 2024 and were signed by:



Mrs S Chowdhury - Director


VASCULAR SONOGRAPHIC DS LIMITED (REGISTERED NUMBER: 07837258)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023


1. STATUTORY INFORMATION

Vascular Sonographic DS Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on reducing balance

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other debtors and creditors.

Basic financial assets, including trade and other debtors, cash and bank balances are initially recognised at transaction price unless the arrangement constitutes a financing transaction where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Basic financial liabilities including trade and other creditors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


VASCULAR SONOGRAPHIC DS LIMITED (REGISTERED NUMBER: 07837258)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2022
and 30 November 2023 1,045
DEPRECIATION
At 1 December 2022 826
Charge for year 44
At 30 November 2023 870
NET BOOK VALUE
At 30 November 2023 175
At 30 November 2022 219

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 19,145 300
Directors' current accounts 40,560 40,309
Prepayments and accrued income - 2,700
59,705 43,309

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 6,564 6,402
Trade creditors 120 1,619
Tax 35,195 11,321
Accruals and deferred income 23,010 13,958
64,889 33,300

VASCULAR SONOGRAPHIC DS LIMITED (REGISTERED NUMBER: 07837258)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Bank loans - 1-2 years 6,730 6,564
Bank loans - 2-5 years 4,004 10,734
10,734 17,298

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

As at the balance sheet date a balance of £40,560 (2022 - £40,309) was owed to the company by the director. No interest has been charged on this balance and it is repayable on demand.

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
VASCULAR SONOGRAPHIC DS LIMITED


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Vascular Sonographic DS Limited for the year ended 30 November 2023 which comprise the Profit and Loss Account, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Vascular Sonographic DS Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Vascular Sonographic DS Limited and state those matters that we have agreed to state to the director of Vascular Sonographic DS Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Vascular Sonographic DS Limited and its director for our work or for this report.

It is your duty to ensure that Vascular Sonographic DS Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Vascular Sonographic DS Limited. You consider that Vascular Sonographic DS Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Vascular Sonographic DS Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






KBSP Partners LLP
Chartered Accountants
Harben House
Harben Parade
Finchley Road
LONDON
NW3 6LH


28 November 2024